Small-Molecule Generative Design for Binding and Synthesis Feasibility
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Developing small molecule drugs that exhibit desirable properties, such as binding affinity to a target site, is challenging due to the vast chemical space of potential molecules, making brute force screening computationally expensive and inefficient.
Innovation Solution
A generative design method iteratively generates and selects molecules based on fitness and diversity scores, using a generative algorithm to modify populations of molecules, ensuring they are structurally diverse and synthetically feasible.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If brute force screening is used to identify candidate molecules, then all possible drug-like molecules can be evaluated, but the computational cost becomes prohibitively expensive
Solution Approach 1:
The patent segments the vast chemical space into manageable subsets by defining specific molecular frameworks (e.g., heterocyclic rings, bicyclic structures) as core templates. This segmentation allows the screening process to focus on variations around these frameworks rather than evaluating all possible molecules, thereby reducing computational cost while maintaining evaluation completeness for drug-like candidates.
Solution Approach 2:
The patent applies preliminary filtering criteria to eliminate molecules that cannot possibly meet drug-like properties before performing detailed binding affinity calculations. By pre-defining constraints on molecular weight, hydrogen bond donors/acceptors, and other pharmacokinetic parameters, the method performs useful action in advance to reduce the pool of molecules requiring expensive computational evaluation.
2Reliability
If the chemical space is explored thoroughly to find potential drug candidates, then binding affinity can be optimized, but the time and resources required increase significantly
Solution Approach 1:
The patent applies local quality by focusing computational resources on specific regions of chemical space defined by particular molecular frameworks. Instead of uniformly exploring all molecules, the method concentrates detailed binding affinity calculations on molecules built around promising core structures (e.g., specific heterocyclic frameworks), thereby optimizing binding affinity for the most relevant candidates while reducing overall screening time.
Solution Approach 2:
The patent employs a dynamic, multi-stage screening approach where the pool of molecules under evaluation is adaptively adjusted based on results from previous stages. Molecules that fail preliminary filters are immediately eliminated, while those passing through are progressively subjected to more computationally intensive analyses only if they maintain promise, creating a dynamic flow that reduces time loss while preserving reliability.
3Quantity of substance
If a large number of molecules are generated and evaluated, then the probability of finding drug candidates increases, but the complexity of the design process increases
Solution Approach 1:
The patent implements a nested hierarchical structure where molecules are built by nesting functional groups and substituents onto core molecular frameworks. This nesting approach systematically generates diverse candidate molecules from a limited set of core structures, increasing the effective quantity of evaluated candidates while reducing design process complexity through modular construction and standardized framework libraries.
Data Source
AI summary
Methods for the generative design of small molecules include performing, until one or more conditions are satisfied, one or more iterations of a generative algorithm. Each iteration of the generative algorithm may include modifying one or more molecules from an initial population of molecules. Moreover, each iteration of the generative algorithm may include selecting, from the initial population of molecules and the one or more modified molecules, a quantity of molecules satisfying one or more fitness scores for inclusion in a subsequent population of molecules. If the one or more conditions are not satisfied, one or more additional iterations of the generative algorithm may be performed using a different initial population of molecules or the subsequent generation of molecules as a new initial population of molecules. Related systems and computer program products are also provided.